CSPG4 and melanoma: These analyses revealed fewer cells in both melanoma cell lines compared to PBS controls, and more cells in the CSPG4-low WM-1361 cells (~17% compared to PBS) compared to the CSPG4-high A375 cells (~5% compared to PBS) 4 days after ADC treatment.